Ontario Ministry of Health. Ontario health survey 1990: Mental health supplement. Toronto: Ontario Ministry of Health; 1994.
2.
BlandRCOrnHNewmanSC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand1988;77(338 Suppl):24–32.
3.
AndrewsGCrinoRHuntCLampeLPageA.The Treatment of anxiety disorders. New York: Cambridge University Press; 1994.
4.
AntonyMMSwinsonRP. Anxiety disorders and their treatment: A critical review of the evidence-based literature. Ottawa: Health Canada; 1996.
5.
KesslerRCMcGonagleKAZhaoSNelsonCBHughesMEshelmanS, and others. Life-time and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the national comorbidity survey. Arch Gen Psychiatry1994;51:8–19.
6.
SteinMBFordeDRAndersonGWalkerJR. Obsessive–compulsive disorder in the community: An epidemiologic survey with clinical reappraisal. Am J Psychiatry1997;154:1120–6.
7.
CoxBJSwinsonRPLeePS. Meta-analysis of anxiety disorder studies. J Clin Psychopharmacol1992;12:300–1.
8.
BarlowDH. Anxiety and its disorders. New York: Guilford; 1988.
9.
SteinMB. Social phobia: Clinical and research perspectives. New York: American Psychiatric Association; 1995.
10.
HeimbergRGLeibowitzMRHopeDASchneierFR. Social phobia: Diagnosis, assessment and treatment. New York: Guilford; 1995.
11.
MarshallJR. Social phobia: From shyness to stage fright. New York: Basic Books; 1994.
12.
FoaEBKozakMJ. Psychological treatment for obsessive compulsive disorder. In: MavissakalianMRPrienRF, editors. Long term treatments of anxiety disorders. Washington (DC): American Psychiatric Press; 1996. p 285–309.
13.
GriestJJeffersonJKobackKKatzelnickDSerlinR.Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Arch Gen Psychiatry1995;52:53–60.